MHC molecules primarily include MHC-I and MHC-II; killing tumor cells by CD8+ T cells required the effective presentation of tumor antigens by human leukocyte antigen class I (HLA-I) molecules [91]. This evidence concerns the gene CD8A and neoplasm.